Bostwick Marketing Mitomics' Prostate Cancer Dx in the US | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mitochondrial DNA diagnostic test development firm Mitomics today announced a non-exclusive deal with Bostwick Laboratories for the marketing and distribution of the Prostate Core Mitomic Test in the US.

The urologic pathology laboratory will market the test under the name ProstaClear Mitomic Test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.